Charles River Laboratories International, Inc. Stock
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
158.04 USD | -0.85% |
|
+2.69% | -14.39% |
Jul. 09 | Evercore ISI Adjusts PT on Charles River Laboratories International to $180 From $170 | MT |
Jul. 09 | Tariff Drama, Minimal Market Reaction | ![]() |
Capitalization | 7.76B 6.64B 6.19B 5.77B 10.62B 668B 11.84B 74.55B 28.26B 312B 29.11B 28.51B 1,145B | P/E ratio 2025 * |
35x | P/E ratio 2026 * | 27.3x |
---|---|---|---|---|---|
Enterprise value | 9.93B 8.5B 7.91B 7.38B 13.59B 854B 15.14B 95.38B 36.16B 400B 37.24B 36.48B 1,465B | EV / Sales 2025 * |
2.55x | EV / Sales 2026 * | 2.4x |
Free-Float |
97.96% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Charles River Laboratories International, Inc.
More recommendations
More press releases
More news
1 day | -0.85% | ||
1 week | +2.69% | ||
Current month | +4.16% | ||
1 month | +5.75% | ||
3 months | +48.26% | ||
6 months | -11.25% | ||
Current year | -14.39% |
1 week | 155.48 | ![]() | 168.12 |
1 month | 143.06 | ![]() | 168.12 |
Current year | 91.86 | ![]() | 193.56 |
1 year | 91.86 | ![]() | 254.15 |
3 years | 91.86 | ![]() | 275 |
5 years | 91.86 | ![]() | 460.21 |
10 years | 59.99 | ![]() | 460.21 |
Manager | Title | Age | Since |
---|---|---|---|
James Foster
CEO | Chief Executive Officer | 74 | 1991-12-31 |
Flavia Pease
DFI | Director of Finance/CFO | 52 | 2022-04-30 |
Birgit Girshick
COO | Chief Operating Officer | 55 | 2021-11-10 |
Director | Title | Age | Since |
---|---|---|---|
James Foster
CHM | Chairman | 74 | 1999-12-31 |
Martin MacKay
BRD | Director/Board Member | 68 | 2017-07-04 |
Virginia Wilson
BRD | Director/Board Member | 70 | 2019-09-30 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
3.05% | 1 M€ | 0.00% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.85% | +2.69% | -26.90% | -24.90% | 7.76B | ||
+0.43% | +1.98% | +9.76% | -0.39% | 50.05B | ||
+0.74% | +4.63% | +65.70% | +43.32% | 29.87B | ||
-0.90% | -1.01% | +2.37% | +6.36% | 28.29B | ||
-1.64% | -1.43% | -28.57% | -24.47% | 27.7B | ||
+0.96% | +1.78% | +27.39% | -22.98% | 12.6B | ||
-0.66% | +1.31% | -55.50% | -27.05% | 11.88B | ||
-0.04% | -0.62% | +26.65% | +104.38% | 10.59B | ||
+0.31% | +1.58% | +11.28% | -1.04% | 10.46B | ||
+1.65% | -0.33% | +45.42% | - | 10.01B | ||
Average | +0.39% | +0.90% | +7.76% | +5.91% | 19.92B | |
Weighted average by Cap. | +0.49% | +0.98% | +10.33% | +5.64% |
2025 * | 2026 * | |
---|---|---|
Net sales | 3.9B 3.34B 3.11B 2.9B 5.34B 335B 5.94B 37.45B 14.2B 157B 14.62B 14.32B 575B | 3.97B 3.4B 3.17B 2.95B 5.44B 342B 6.06B 38.16B 14.47B 160B 14.9B 14.59B 586B |
Net income | 222M 190M 177M 165M 303M 19.06B 338M 2.13B 807M 8.92B 831M 814M 32.7B | 273M 233M 217M 203M 373M 23.46B 416M 2.62B 993M 10.98B 1.02B 1B 40.25B |
Net Debt | 2.17B 1.86B 1.73B 1.61B 2.97B 186B 3.31B 20.83B 7.9B 87.25B 8.13B 7.97B 320B | 1.79B 1.53B 1.43B 1.33B 2.45B 154B 2.73B 17.21B 6.53B 72.11B 6.72B 6.58B 264B |
More financial data
* Estimated data
Employees
19,400
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-07-14 | 158.04 $ | -0.85% | 646,945 |
25-07-11 | 159.40 $ | -2.60% | 518,978 |
25-07-10 | 163.66 $ | +2.95% | 828,706 |
25-07-09 | 158.97 $ | +0.37% | 653,998 |
25-07-08 | 158.39 $ | +2.92% | 752,391 |
Delayed Quote Nyse, July 14, 2025 at 04:00 pm EDT
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
158.04USD
Average target price
159.67USD
Spread / Average Target
+1.03%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CRL Stock
Select your edition
All financial news and data tailored to specific country editions